ATE474575T1 - Pyridinverbindungen, ihre verfahren zur herstellung und anwendung - Google Patents

Pyridinverbindungen, ihre verfahren zur herstellung und anwendung

Info

Publication number
ATE474575T1
ATE474575T1 AT00904436T AT00904436T ATE474575T1 AT E474575 T1 ATE474575 T1 AT E474575T1 AT 00904436 T AT00904436 T AT 00904436T AT 00904436 T AT00904436 T AT 00904436T AT E474575 T1 ATE474575 T1 AT E474575T1
Authority
AT
Austria
Prior art keywords
pyridine compounds
production
compounds
useful
pyridine
Prior art date
Application number
AT00904436T
Other languages
English (en)
Inventor
Robert Struck
Herbert Blatter
Anita Tiwari
Original Assignee
Southern Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Res Inst filed Critical Southern Res Inst
Application granted granted Critical
Publication of ATE474575T1 publication Critical patent/ATE474575T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00904436T 1999-01-21 2000-01-21 Pyridinverbindungen, ihre verfahren zur herstellung und anwendung ATE474575T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11667699P 1999-01-21 1999-01-21
PCT/US2000/001337 WO2000043009A1 (en) 1999-01-21 2000-01-21 Pyridine compounds, use and preparation thereof

Publications (1)

Publication Number Publication Date
ATE474575T1 true ATE474575T1 (de) 2010-08-15

Family

ID=22368577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00904436T ATE474575T1 (de) 1999-01-21 2000-01-21 Pyridinverbindungen, ihre verfahren zur herstellung und anwendung

Country Status (8)

Country Link
EP (1) EP1143970B1 (de)
JP (1) JP4709386B2 (de)
AT (1) ATE474575T1 (de)
AU (1) AU2619700A (de)
DE (1) DE60044708D1 (de)
ES (1) ES2348972T3 (de)
PT (1) PT1143970E (de)
WO (1) WO2000043009A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4709387B2 (ja) * 1999-01-21 2011-06-22 サザン・リサーチ・インスティテュート 4−デメチルペンクロメジンのアシル誘導体、その使用及び調製
WO2007070568A2 (en) * 2005-12-13 2007-06-21 Dekk-Tec, Inc. Demethylpenclomedine analogs and their use as anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3244722A (en) * 1964-01-28 1966-04-05 Dow Chemical Co Certain ethers of (trichloromethyl) pyridine compounds
US4717726A (en) * 1986-09-10 1988-01-05 The Dow Chemical Company 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine having anti-tumor activity
WO1997046531A1 (en) * 1996-06-03 1997-12-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pyridine derivative, composition and method for treating cancer
JP4709387B2 (ja) * 1999-01-21 2011-06-22 サザン・リサーチ・インスティテュート 4−デメチルペンクロメジンのアシル誘導体、その使用及び調製

Also Published As

Publication number Publication date
PT1143970E (pt) 2010-10-27
JP4709386B2 (ja) 2011-06-22
AU2619700A (en) 2000-08-07
ES2348972T3 (es) 2010-12-20
EP1143970A1 (de) 2001-10-17
EP1143970A4 (de) 2005-07-27
EP1143970B1 (de) 2010-07-21
JP2002535275A (ja) 2002-10-22
WO2000043009A1 (en) 2000-07-27
DE60044708D1 (de) 2010-09-02

Similar Documents

Publication Publication Date Title
ATE348098T1 (de) Verfahren und zwischenprodukte zur herstellung von antikrebsmitteln
DE69941954D1 (de) Oxetanderivate, oxetancopolymer, und verfahren zur herstellung von oxetanderivaten
ATE306252T1 (de) Verfahren zur herstellung kristalliner partikel zur inhalation
ATE322252T1 (de) Verfahren zur herstellung und sammlung von kristallinen partikeln
DE60228846D1 (de) Neue mesogene, verfahren zu deren herstellung und verwendung
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
DE60316152D1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
DE60115358D1 (de) Geformter Katalysator zur Herstellung von Triethylendiamin, Verfahren zu dessen Herstellung, und Verfahren zur Herstellung von Triethylendiamin
DE602004003037D1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
DE50012584D1 (de) Keramikhaltiges dispergat, verfahren zu dessen herstellung und verwendung des dispergates in dickschichtpasten
AR005619A1 (es) Procedimiento para preparar compuestos dicetonicos
ATE474575T1 (de) Pyridinverbindungen, ihre verfahren zur herstellung und anwendung
ATE264828T1 (de) Verfahren zur herstellung von biarylen
DE60106057D1 (de) Verfahren zur herstellung von baccatin iii-derivativen
ATE440605T1 (de) Verfahren zur herstellung von camptothecin- derivaten
DE69916332D1 (de) Verfahren zur herstellung von etheraminalkoxylaten
DE60044804D1 (de) Acylderivate des 4-demethylpenclomedins, verwendung und zubereitung derselben
ATE258571T1 (de) Verfahren zur herstellung von thiazin- indigoverbindungen und von neuen zwischenprodukten dafür
ATE466847T1 (de) Verfahren zur herstellung von 14-beta- hydroxybaccatin-iii-1,14-carbonat
ATE537160T1 (de) Verfahren zur herstellung von 14beta- hydroxybaccatin-iii-1,14-carbonat
DE60002260D1 (de) Verfahren zur Herstellung von Adamantanolen
DE69917440D1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
DE50012273D1 (de) Vorrichtung zur Herstellung von Presslingen
DE59907804D1 (de) Verbessertes verfahren zur herstellung von pharmazeutisch wertvollen norbenzomorphanderivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1143970

Country of ref document: EP